NCT00004104 2016-03-31
Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
NYU Langone Health
Phase 2 Completed
Clinical Trials
8 trialsNCT02074605 2014-02-28
Cognitive Effects of Interferon in Patients With Melanoma
University of Arizona
Completed
NCT00004196 2014-01-20
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
University of Alabama at Birmingham
Phase 3 Completed
NCT00447356 2013-05-13
High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
Hackensack Meridian Health
Phase 3 Withdrawn
NCT00005615 2012-09-25
Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Completed
NCT00002882 2011-12-13
Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00003091 2011-05-12
High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
Hoag Memorial Hospital Presbyterian
Phase 2 Completed
NCT00002733 2011-05-11
Biological Therapy in Treating Patients With Metastatic Cancer
Hoag Memorial Hospital Presbyterian
Phase 2 Completed